Skip to main content

Table 1 Sample and linear regression characteristics for all subjects contrasted by study.

From: The six minute walk test accurately estimates mean peak oxygen uptake

Study

Sample Characteristics

Linear Regression Statistics

 

Disease

n

peak VO2 Mean ± SD

6 MWT Mean ± SD

Slope

Intercept

R

SEE

(SEE/Mean) × 100

Cahalin 1996 (3)

CHF

45

12.4 ± 4.5

310 ± 103

0.028

3.583

0.65

3.44

27.7

Cahalin 1995 (2)

ESLD

60

9.6 ± 3.8

294 ± 139

0.019

4.042

0.69

2.81

29.2

Lucas 1999 (6)

CHF

307

14.2 ± 4.9

391 ± 105

0.027

3.666

0.59

3.99

28.1

Miyamoto 2000 (7)

PH

27

13.9 ± 4.4

377 ± 115

0.026

4.213

0.68

3.25

23.4

Opasich 2001 (8)

CHF

269

14.5 ± 4.9

378 ± 95

0.027

4.498

0.59

3.42

23.6

Roul 1998 (9)

CHF

114

16.8 ± 4.5

437 ± 108

0.009

12.910

0.21

4.43

26.4

Starobin 2006 (10)

COPD

49

14.0 ± 4.4

436 ± 89

0.027

2.184

0.55

3.69

26.4

Zugck 2000 (11)

DC

112

15.6 ± 5.2

463 ± 107

0.033

0.113

0.69

3.78

24.2

Faggiano 1997 (4)

CHF

26

15.1 ± 3.9

419 ± 121

0.019

7.260

0.58

3.25

20.8

Lipkin 1986 (5)

CHF

26

14.0 ± 4.1

452 ± 147

0.019

5.271

0.70

2.95

21.0

Baylor

CPD

48

13.1 ± 3.4

354 ± 131

0.017

6.921

0.68

2.50

19.1

All Data

All

1,083

14.3 ± 4.8

393 ± 115

0.025

4.682

0.59

3.82

26.7

  1. ESLD - End Stage Lung Disease; DC - Dilated Cardiomyopathy; CHF - Congestive Heart Failure; PH -Pulmonary Hypertension; COPD - Chronic Obstructive Pulmonary Disease; CPD - Various Cardiopulmonary Disorders. Peak VO2 - peak oxygen uptake (ml/kg/min.); 6 MWD- distance walked (meters) during the 6-minute walk test.